FIA
DWTX

FNY Investment Advisers’s Dogwood Therapeutics DWTX Stock Holding History

FNY Investment Advisers’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,500
Closed -$62K – 1225
2025
Q1 		$62K Buy
+12,500
New +$84.6K 0.04% 267
2021
Q1 		– Sell
-40
Closed -$7K – 1059
2020
Q4 		$7K Buy
+40
New +$9.64K ﹤0.01% 622

Other funds holding DWTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FNY Investment Advisers's DWTX Position: Q2 2025 in Review

FNY Investment Advisers sold out of Dogwood Therapeutics (DWTX) in Q2 2025, closing a stake of 12,500 shares — an estimated $62K sold.

FNY Investment Advisers first reported a position in DWTX in Q4 2020 and held it in 2 quarters. The position peaked at $62K in Q1 2025. 10 funds tracked by Wall St. Rank hold DWTX as of Q2 2025.

  • FNY Investment Advisers reported no remaining Dogwood Therapeutics position as of Q2 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 12,500 Dogwood Therapeutics shares in Q2 2025, an estimated $62K.
  • FNY Investment Advisers first reported a position in Dogwood Therapeutics in Q4 2020 and held it in 2 quarters.
  • FNY Investment Advisers's Dogwood Therapeutics position peaked at $62K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2025.

Based on FNY Investment Advisers's 13F filing for Q2 2025, filed 30 Jul 2025.